Analysis of Inventory
Paying user area
Try for free
Medtronic PLC pages available for free this week:
- Common-Size Income Statement
- Common-Size Balance Sheet: Assets
- Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
- Common Stock Valuation Ratios
- Capital Asset Pricing Model (CAPM)
- Operating Profit Margin since 2005
- Return on Assets (ROA) since 2005
- Debt to Equity since 2005
- Price to Operating Profit (P/OP) since 2005
- Price to Book Value (P/BV) since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Medtronic PLC for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Inventory Disclosure
Medtronic PLC, balance sheet: inventory
US$ in millions
| Apr 24, 2026 | Apr 25, 2025 | Apr 26, 2024 | Apr 28, 2023 | Apr 29, 2022 | Apr 30, 2021 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Finished goods | |||||||||||||
| Work-in-process | |||||||||||||
| Raw materials | |||||||||||||
| Inventories |
Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).
Total inventories exhibit a consistent upward trajectory over the analyzed six-year period, increasing from US$ 4,313 million in April 2021 to US$ 5,951 million by April 2026. While the overall trend is positive, a brief period of stabilization occurred between April 2023 and April 2024, during which total inventory levels decreased slightly from US$ 5,293 million to US$ 5,217 million before resuming growth.
- Finished Goods Expansion
- Finished goods represent the most significant component of the inventory portfolio and have grown steadily in every reporting period. The value increased from US$ 2,906 million in 2021 to US$ 4,075 million in 2026. This continuous growth suggests a sustained expansion in production output or a strategic increase in safety stock to meet evolving market demand.
- Raw Materials and Work-in-Process Volatility
- Both raw materials and work-in-process inventories followed a synchronized pattern of growth followed by a temporary contraction. Raw materials rose from US$ 796 million in 2021 to a peak of US$ 1,063 million in 2023, before declining to US$ 907 million in 2024 and recovering to US$ 1,076 million by 2026. Similarly, work-in-process peaked at US$ 789 million in 2023, dipped to US$ 642 million in 2024, and ended at US$ 800 million in 2026. These parallel movements indicate a period of inventory optimization or supply chain recalibration during the 2023-2024 fiscal window.
- Inventory Composition Analysis
- The total inventory value is heavily weighted toward finished goods, which consistently comprise the majority of the overall balance. The relative stability in the proportion of finished goods versus the combined value of raw materials and work-in-process suggests a consistent operational model, although the increase in absolute values across all categories points to a general scaling of the company's operational footprint.